Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Life Science Tools & Manufacturing

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Infectious Pathogen Diagnostics Technology Commercialization

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

Voice-of-Customer Research

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

Voice-of-Customer Research

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

Voice-of-Customer Research

High-Level Commercial Due Diligence in Digital Pathology

An early-stage venture firm requested a high-level commercial due diligence of a potential investment

Due Diligence

Precision Medicine is evolving at a rapid pace

Discover how we can help